FindTrial
Sign In

Once daily

DRUG3 trials

Sponsors

Babol University of Medical Sciences, Oklahoma State University Center for Health Sciences, ViiV Healthcare Company

Conditions

Condition 1: metabolic syndrome. Condition 2: bipolar disorder with psychotic feature. Metabolic syndrome Bipolar disorder, current episode depressed, severe, with psychotic featuresHIV InfectionsNaive HIV&#45

Phase 3

An open label, single arm study of the safety and efficacy of DTG/3TC in therapy-naïve HIV-1 infected adolescents.
Active, not recruitingTCTR20180817004
ViiV Healthcare CompanyNaive HIV&#45
Start: 2018-10-29Target: 30Updated: 2026-08-03
Metformin efficacy in metabolic syndrome; dapagliflozin in metabolic syndrome
RecruitingIRCT20250712066463N1
Babol University of Medical SciencesCondition 1: metabolic syndrome. Condition 2: bipolar disorder with psychotic feature. Metabolic syndrome Bipolar disorder, current episode depressed, severe, with psychotic features
Start: 2025-07-21Target: 54Updated: 2025-08-19

Phase 4

Kaletra and Viread in Antiretroviral Naïve Patients
TerminatedNCT00679926
Oklahoma State University Center for Health SciencesHIV Infections
Start: 2008-05-31End: 2011-05-31Updated: 2020-12-04